Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Giovanni Barosi, MD, Mohan Agarwal, MD, MNAMS, Sonja Zweegman, MD, PhD, Wolfgang Willenbacher, MD, Sima Pakstyte, MD, Reinier Raymakers, MD, PhD, Nathan Cantoni, MD, Ankur Modi, Mahmudul Khan, PhD, Jose Ricardo Perez, MD, Hans Hasselbalch, MD, Jose Pablo Vargas Viveros, MD, Camila C.G. Linardi, MD, PhD, Heinz Gisslinger, MD, Adelmo Henrique Daumas Gabriel, MD, Francesca Palandri, David Lavie, MD, Claire N Harrison, DM FRCP FRCPath

Blood (2012) 120 (21): 2844.

https://doi.org/10.1182/blood.V120.21.2844.2844

Published: 2012

Journal Articles

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

Angel Ruedas, MD, Pablo Guisado, MD, PhD, Beatriz Aguado, MD, PhD, Ricardo Perez, MD, Joaquin Martinez, MD, J Valentin Garcia-Gutierrez, MD, PhD, M. Jesús Blanchard, MD, Pilar Bravo, MD, Carlos Montalban

Blood (2012) 120 (21): 5049.

https://doi.org/10.1182/blood.V120.21.5049.5049

Published: 2012

Journal Articles

A Ruxolitinib Individual Supply Program for Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Giovanni Barosi, MD, Francisco Cervantes, MD, PhD, Dina Ben-Yehuda, MD, Panagiotis Panagiotidis, Jose Ricardo Perez, MD, Nancy D. Orlando-Harper, Nicolas Martin, MS, Wolfgang Willenbacher, MD, Emilio Ojeda, MD, PhD, Heinz Gisslinger, MD, Laurent Knoops, MD, PhD

Blood (2011) 118 (21): 5170.

https://doi.org/10.1182/blood.V118.21.5170.5170

Published: 2011

Journal Articles

Tailored Low Dose Lenalidomide with Low Dose Dexamethasone (len/dex) in Previously Treated Patients with Multiple Myeloma Older Than 70 Years Requiring Treatment.

Angel Ruedas, MD, Ricardo Perez, MD, Valentin Garcia, MD, Alicia Smucler, MD, Pilar Bravo, MD, Joaquin Martinez, MD, Pilar Sabin, MD, Pablo Guisado, MD, PhD, Carlos Montalban, PHD

Blood (2009) 114 (22): 4950.

https://doi.org/10.1182/blood.V114.22.4950.4950

Published: 2009

Journal Articles

Up-Front Treatment of Diffuse Large-B Cell Lymphoma (DLBCL) in Elderly Patients with Rituximab in Combination with CHOP-Like Chemotherapy: A Multicenter Study on the Current Clinical Management.

Miguel A. Canales, MD, PhD, Javier de la Serna, MD, Pilar Sabin, MD, Joaquin Diaz-Mediavilla, MD, Mariano Provencio, MD, Rosa Ayala, MD, Ricardo Perez, MD, Ana Alvarez, MD, Antonio Sanchez, MD, Raquel Gil, Fernando Hernandez-Navarro, MD, PhD

Blood (2005) 106 (11): 4778.

https://doi.org/10.1182/blood.V106.11.4778.4778

Published: 2005

NARROW

An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

A Ruxolitinib Individual Supply Program for Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Tailored Low Dose Lenalidomide with Low Dose Dexamethasone (len/dex) in Previously Treated Patients with Multiple Myeloma Older Than 70 Years Requiring Treatment.

Up-Front Treatment of Diffuse Large-B Cell Lymphoma (DLBCL) in Elderly Patients with Rituximab in Combination with CHOP-Like Chemotherapy: A Multicenter Study on the Current Clinical Management.

Email alerts

ASH Publications

American Society of Hematology

An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

A Ruxolitinib Individual Supply Program for Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Tailored Low Dose Lenalidomide with Low Dose Dexamethasone (len/dex) in Previously Treated Patients with Multiple Myeloma Older Than 70 Years Requiring Treatment.

Up-Front Treatment of Diffuse Large-B Cell Lymphoma (DLBCL) in Elderly Patients with Rituximab in Combination with CHOP-Like Chemotherapy: A Multicenter Study on the Current Clinical Management.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only